Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.

Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. Br J Haematol. 2016 07; 174(2):235-48.

View in: PubMed

subject areas

Adult
Aged
Disease Progression
Disease-Free Survival
Drug Resistance
Hematopoietic Stem Cell Transplantation
Humans
Lymphoma, Large B-Cell, Diffuse
Middle Aged
Myeloablative Agonists
Prognosis
Recurrence
Remission Induction
Risk Assessment
Survival Rate
Transplantation Conditioning
Transplantation, Autologous
Transplantation, Homologous
Treatment Outcome
Young Adult

authors with profiles

Sunita Nathan